RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Operating cash flow, 2025
- $2.5B
- YoY, 2025
- −10.1%
- 5-year CAGR
- +4.1%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $2.5B | −10.1% |
| 2024 | $2.8B | −7.3% |
| 2023 | $3.0B | +39.4% |
| 2022 | $2.1B | +6.3% |
| 2021 | $2.0B | −0.8% |
| 2020 | $2.0B | +22.0% |
| 2019 | $1.7B | +3.0% |
| 2018 | $1.6B | — |